Persen

Quick links to important sections

Persen

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Persen

Quick Facts

Property Description
Active Ingredients Valerian Root, Lemon Balm Leaf, Peppermint Leaf
Form Oral Tablet or Capsule
Pharmacological Class Herbal Sedative/Anxiolytic Combination
General Purpose Relieves mild nervous tension and aids relaxation
Origin Plant-based (Phytomedicine)

What Type of Medicine is Persen?

Persen is a well-established phytomedicine, or herbal preparation, generally classified as a mild, over-the-counter sedative and anxiolytic. It is a combination medicine composed of three plant extracts used to promote relaxation and help manage mild nervous tension. These herbal components are recognized for their traditional use in addressing nervousness and sleep.

As a combination preparation, Persen is differentiated by its specific blend of active plant extracts, designed to achieve a synergistic calming effect. It is typically positioned for an adult patient group seeking relief from daily stress and is intended for oral administration as a reliable, standardized solid dose.

Composition and Physical Form

Persen contains the dried extracts of Valerian root (Valeriana officinalis), Lemon Balm leaf (Melissa officinalis), and Peppermint leaf (Mentha piperita). This specific three-part formulation is based on traditional use and recognized for its calming properties. The selection of these herbs is intentional, with each contributing to the overall purpose of promoting a more relaxed state.

The medicine is commonly available as an oral tablet or a capsule. This solid, standardized formulation ensures a uniform dose of the herbal extracts. The inclusion of peppermint leaf extract provides a distinctive feature, helping to ease mild digestive discomfort often associated with emotional tension.

What is Persen Generally Used For?

Persen is used to help the body soothe an overactive nervous system and assist in the natural process of relaxation. It helps to reduce restlessness and ease the physical and emotional symptoms associated with mild daily stress, such as feeling keyed up or having difficulty winding down.

By promoting a calmer internal state, the medicine supports the mind and body in transitioning more easily into a restful condition. This overall calming effect is beneficial for supporting a healthier ability to fall asleep and for relieving feelings of mild anxiety that can interfere with normal routine.

Regulatory References

  1. NIH Valerian Fact Sheet

What side effects are possible with Persen?

Possible Side Effects and Safety Information

Adverse reactions documented for Persen, which contains Valerian root, Lemon Balm, and Peppermint extracts, are generally non-serious and are classified by official regulatory bodies primarily within the Gastrointestinal and Nervous System domains.

Reported adverse effects typically include nausea, abdominal cramps, and diarrhoea (Gastrointestinal Disorders), alongside dizziness and headache (Nervous System Disorders). The occurrence of nightmares or vivid dreams has also been noted (Psychiatric Disorders). As is common for many herbal preparations, the exact frequency of these effects is often officially classified as Not Known due to limitations in available post-marketing data.

Safety Considerations and Restrictions

Regulatory documentation outlines specific constraints regarding the use of this medicine:

  • Vulnerable Populations: Use is not recommended for children under 12 years and is likewise not recommended during pregnancy or lactation because insufficient data exists to establish safety in these groups.
  • Impairment of Abilities: Due to the potential for sedative effects, the medicine may impair the ability to drive or operate machinery.
  • Co-medication Risk: Caution is required as additive sedative effects cannot be excluded if used concurrently with other sedatives or hypnotics, and the effects may be potentiated by alcohol.
  • Component-Specific Cautions: Due to the Peppermint leaf component, individuals with pre-existing conditions such as gallbladder issues or Gastroesophageal Reflux Disease (GERD) should note specific constraints documented in the official labeling.

These safety classifications define the medicine’s risk profile by detailing the physiological systems affected, flagging potential drug-substance interactions, and formally restricting use in certain populations where safety has not been fully established.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below summarizes the documented overdose profile as stated in authoritative government regulatory documents for this phytomedicine.

Category Official Regulatory Statement
Documented Overdose Manifestations Symptoms following massive ingestion may include fatigue, abdominal cramps, dizziness, hand tremor, mydriasis (pupil dilation), and a feeling of chest tightness
Severity Classification Overdose effects are generally classified as mild and transient, with spontaneous resolution typically occurring within 24 hours
Antidote Information No specific antidote is known for the overdose of this herbal combination
Supportive Management Treatment is officially documented as symptomatic and supportive treatment, which may include the use of activated charcoal and clinical monitoring

Required Emergency Action

Regulatory authorities explicitly mandate that the ingestion of a dose substantially higher than recommended necessitates seeking immediate medical attention. This action is required regardless of the generally mild and self-limiting nature of the documented symptoms. When signs of overdose, such as excessive fatigue or notable physical symptoms, become apparent, patients are instructed to contact emergency services immediately. Prolonged hospital observation may be required following an acute ingestion event to monitor clinical status and ensure complete recovery.

Therapeutic Uses of Persen

What Persen Treats: Main Uses and Benefits

The traditional therapeutic uses of the herbal combination in Persen are considered relevant for supportive benefit in managing mild nervous system symptoms. The primary active component (Valerian root) has a traditional use for the relief of mild nervous tension and to aid sleep.


Managing Mild Nervous Tension and Restlessness

The medicine is commonly used to help with conditions characterized by periods of increased emotional tension, managing symptoms such as irritability, feeling keyed up, and nervous restlessness. It provides support that helps ease the overall symptom burden, supporting general well-being during symptomatic phases. Persen is relevant in situations where patients experience difficulty in winding down, particularly when symptoms may interfere with the ability to relax before bed. It contributes to easing the overall symptom load, offering supportive relief that may help patients cope more steadily with symptom fluctuations related to sleep. The medication is also used for addressing accompanying symptoms related to physical discomfort, such as mild digestive discomfort linked to nervous tension.


Quick Fact: Symptomatic Support for Mild Nervous Tension

Symptom Category Relief Focus
Nervous Tension Managing irritability and feeling keyed up
Sleep Easing difficulty in winding down and sleep onset
Physical Symptoms Supportive relief for mild, stress-related digestive discomfort

Regulatory References

  1. European Union herbal monograph on Valeriana officinalis L., radix

Eligibility and Restrictions for Use

Who Can and Cannot Use Persen?

Eligibility to use Persen is strictly defined by official regulatory documentation and is based on age, existing hypersensitivity, and reproductive status.

Approved and Non-Approved Populations

Eligibility Group Status Based on Official Labeling
Adults (18 years and older) Approved Population
The Elderly Approved Population
Children and Adolescents (Under 18) Not Recommended (Safety not established)
Pregnant Women Not Recommended (Insufficient data)
Breast-feeding Women Not Recommended (Insufficient data)

Absolute Contraindications and Restrictions

Persen is contraindicated for individuals with known hypersensitivity or allergy to the active ingredients—Valerian root, Lemon Balm leaf, Peppermint leaf—or to any of the specific tablet or capsule excipients.

Regulatory agencies classify use in individuals under 18, during pregnancy, and during lactation as not recommended due to a lack of sufficient clinical data to establish safety and efficacy in these specific populations.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Persen

Interaction Scope

Detail Official Regulatory Statement
Medicinal product categories with documented interactions CNS Depressants (e.g., Hypnotics, Sedatives), Sedating Herbal Products.
Specific interacting medicines (if explicitly listed) Barbiturates.
Mechanistic basis of interactions (only if stated in label) Pharmacodynamic Reinforcement (Additive sedative effect). Clinically relevant Pharmacokinetic Interactions (CYP 2D6, 3A4/5, 1A2, 2E1) not observed.
Timing-based interaction rules (if applicable) None documented requiring a specific mandatory separation window.
Population-specific interaction notes (if applicable) Caution regarding Ethanol content (in liquid formulations) for patients with alcohol dependence or liver problems.
Interaction-related restrictions Excessive concomitant consumption of alcohol should be avoided. Co-medication with other sedatives is not recommended.

Interaction Classifications (High-Level)

Classification Official Regulatory Statement
Interaction severity classification (as defined in official documents) Precaution / Not Recommended.
Regulatory basis (EMA / FDA / etc.) European Medicines Agency (EMA) and National Medicines Authority Monographs.
Interaction-context constraints (as defined in official documents) Interaction risk is primarily linked to the potential for an additive CNS depressant effect.

Resulting Interaction Structure

Official interaction statements:

  • Co-medication with barbiturates and other sedatives is not recommended due to the possibility of an additive sedative effect, which constitutes pharmacodynamic reinforcement.
  • The effect of the product may be potentiated by alcohol (ethanol), requiring that excessive concomitant consumption of alcohol should be avoided.
  • Regulatory reports indicate that clinically relevant pharmacokinetic interactions involving major metabolic pathways (CYP 2D6, CYP 3A4/5, CYP 1A2, CYP 2E1) have not been observed.
  • Caution for the ethanol content in liquid formulations is required for specific populations, including those with alcohol dependence or liver problems.

Connection to the overall interaction profile (3 sentences): Regulatory documents define this product's interaction structure as predominantly driven by a pharmacodynamic interaction risk, specifically the potentiation of CNS depression when co-administered with alcohol or other sedatives. The official profile relies on this singular mechanistic basis to issue restrictions against co-administration with these categories of substances. The regulatory framework confirms the low likelihood of clinically significant pharmacokinetic interactions involving major CYP enzymes, thereby limiting the primary risk to additive sedative effects.

Mechanism of Action

Mechanism of Action

Persen exerts its effects through the combined pharmacodynamic activity of its primary botanical constituents, Valerian and Lemon Balm, focusing on modulating central nervous system (CNS) signaling. Valerian extracts, primarily valerenic acid derivatives, function as positive allosteric modulators of the GABA-A receptor complex. This interaction enhances the binding affinity of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), to its receptor site, resulting in increased chloride ion (Cl^-) conductance across the neuronal membrane. This Cl^- influx leads to neuronal hyperpolarization, effectively reducing cellular excitability and modulating the rate of neuronal firing across various brain regions.

Simultaneously, Lemon Balm (Melissa officinalis) components, such as rosmarinic acid, contribute to the mechanism by inhibiting the enzyme GABA transaminase (GABA-T). This enzymatic inhibition reduces the metabolic breakdown of GABA within the synaptic cleft, biochemically resulting in higher functional concentrations of GABA available for receptor interaction. The synergistic enhancement of GABAergic neurotransmission through both allosteric receptor modulation and reduced catabolism results in a system-level physiological consequence: a general dampening of excitation signals and an overall reduction in CNS hyperactivity. Peppermint (Mentha piperita) provides secondary peripheral modulation through effects on smooth muscle tissue and autonomic tone.

Dosage and Administration Information

How Persen is Used: Administration Guidelines

The usage of Persen, a combination herbal preparation, focuses on the correct oral administration and adherence to specific dosing schedules for its intended supportive use. The medicine is provided in a solid dose form (tablet or capsule) which must be swallowed whole with fluid, irrespective of mealtimes.


Administration and Dosing Schedule

Administration is structured around the patient's intended use, requiring regular and consistent intake rather than acute, on-demand use. The product is not suitable for acute interventional treatment due to its gradual onset of action.

Usage Goal Standard Dosing Regimen
Mild Nervous Tension Typically, one dose (tablet/capsule) is taken two to three times per day (divided doses).
To Aid Sleep A single dose is taken approximately 0.5 to 1 hour before intended bedtime.

Use Over Time and Population Rules

To achieve the expected effect, continued, regular use over a period of 2 to 4 weeks is recommended before determining the benefit of the preparation. If symptoms persist or worsen after two weeks of use, consultation with a healthcare professional is advised.

Crucially, the administration rules specify a population exclusion: The use of Persen and similar Valerian-based preparations is not recommended for children under 12 years of age, primarily due to limited data to support its use in this age group.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Persen

Evidence for Use in Mild Nervous Tension and Restlessness

The research base exploring mild nervous tension and restlessness, which are conditions characterized by fluctuating or episodic manifestations, largely consists of short-term randomized controlled trials (RCTs) and systematic reviews. These studies primarily focused on Valerian and Lemon Balm, both individually and in combination, in adult populations and healthy volunteers. Researchers monitored changes in subjective ratings of nervousness, general anxiety, and restlessness. Systematic reviews have highlighted that the findings were mixed and showed considerable variability, particularly when different herbal preparations were compared.

Consistency across formulations is not fully established regarding the patterns across all preparations, and research exploring short-term symptom changes provides limited insight into long-term outcomes. Follow-up durations were limited, meaning information regarding consistent use beyond a few weeks is limited, and results apply mainly to the populations studied.

Research Examining Sleep and Minor Sleep Disorders

Studies examining the herbal components exploring outcomes related to sleep primarily involve RCTs, systematic reviews, and meta-analyses of Valerian root and Valerian combined with Lemon Balm. These trials were evaluated in populations including adults reporting sleep disturbances and the elderly. The main outcomes studies monitored were subjective measurements of sleep, such as the reported time taken to fall asleep (sleep latency) and overall sleep quality scores. Evidence reviews consistently describe significant heterogeneity (variability) in the data due to wide differences in the specific species, extraction methods, and dosage levels of the preparations used.

Few data are available for long-term outcomes, and follow-up durations were limited. The reliance on self-reported outcomes and the methodological limitations of some trials underscore limitations in establishing consistent conclusions.

Research Gaps and Areas of Uncertainty

Research highlights what is known—and what is still uncertain. The primary research limitations include significant heterogeneity in the herbal preparations used across different trials, which complicates efforts to establish consistent patterns for specific marketed products. The quality of the evidence varies across studies, and follow-up durations were limited. This means that comparative evidence against other standard therapies is often lacking, and there is limited information for long-term outcomes. Researchers acknowledge that data are still emerging and certainty remains low in several areas of the research landscape.

Key Studies & References

  1. European Union herbal monograph on Valeriana officinalis L., radix (Valerian root)
  2. Valerian for sleep: a systematic review and meta-analysis (Stevinson, Ernst 2000; DARE Review)
  3. A systematic review of valerian as a sleep aid: Safe but not effective (Taibi et al. 2007)
  4. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) (Kennedy et al. 2002)

Frequently Asked Questions (FAQ)

Common questions about Persen (FAQ)


Q: Does Persen contain ingredients that are considered habit-forming or addictive?

Official information regarding Valerian root, a key ingredient, has noted that dependence and withdrawal symptoms may be associated with discontinuing its use after taking it for a long period. This caution is mentioned in official product information because the medicine affects the central nervous system. Concerns about dependence are often discussed with a healthcare provider.


Q: How quickly can someone generally expect to feel the effects of Persen?

Regulatory guidance suggests that Persen has a gradual onset of action, meaning it is not considered suitable for acute, one-time treatment. To experience the optimal intended effect for mild nervous tension or to aid sleep, continued, regular use over a period of two to four weeks is officially recommended.


Q: Are there different strengths or versions of Persen, like 'Forte'?

While regulatory documents primarily describe the standard, standardized solid dose formulation, it is common for commercial manufacturers to produce variants. These can include versions like ‘Forte’ which typically contain different, higher concentrations of the active herbal extracts. Details on specific strengths would be found on individual product labels.


Q: Is it possible to experience unusual or severe side effects from Persen?

Official documentation lists common, generally non-serious adverse reactions like nausea, abdominal cramps, and headache. However, as with all medicines, official patient safety guidelines describe scenarios where seeking medical attention is necessary, such as if signs of a severe allergic reaction (swelling, difficulty breathing) are suspected.


Q: Does Persen have any reported interactions with common pain relievers or cold medicines?

Official warnings state that co-medication is strongly cautioned with other Central Nervous System (CNS) depressants, which can include some pain and cold remedies that cause drowsiness. This is due to the potential for an undesirable additive sedative effect. The official profile does not specifically address interactions with non-sedating classes of these over-the-counter medicines.


Q: Can Persen be taken alongside herbal supplements, such as Ashwagandha?

Official warnings caution against taking Persen with other sedating herbal products because of the potential for additive sedative effects. For non-sedating supplements, such as Ashwagandha, specific interactions are often not formally documented in product monographs. Combining herbal products is typically a topic for discussion with a healthcare professional for individual guidance.


Q: What makes Persen different from a benzodiazepine medication?

Persen is officially described as a mild, plant-based herbal sedative, positioning it differently from prescription drug classes like benzodiazepines. Its Valerian component affects the GABA-A receptor complex in the brain, similar to benzodiazepines, but acts at a distinct site. This mechanism is thought to achieve a dampening of excitation signals, but is structurally and regulatorily separate from controlled benzodiazepine medications.


Q: Are there specific food or beverage recommendations to follow while taking Persen?

Official patient information states that Persen can be taken regardless of mealtimes. The most critical official instruction regarding consumption is to strictly avoid the excessive, concomitant intake of alcohol, as this can increase the product’s sedative effects.


Q: Is it known if Persen can cause liver problems or affect liver function tests?

Regulatory documents state that caution is necessary for patients with pre-existing liver problems when using liquid formulations, due to their potential ethanol content. General safety literature for valerian-containing products indicates that liver issues are rare but a possibility; individuals with liver concerns are typically advised to consult a healthcare professional regarding use.


Q: Can Persen cause stomach upset, nausea, or other digestive issues?

Official documentation lists several common adverse effects within the Gastrointestinal domain. These reported side effects generally include nausea, abdominal cramps, and diarrhea. If these or other digestive issues persist or become severe, further advice from a healthcare professional may be needed.


Q: What should be done if an allergic reaction to an ingredient in Persen is suspected?

Official information lists hypersensitivity or allergy to the active ingredients as an absolute contraindication. In line with general patient safety guidelines, if signs of a suspected allergic reaction, such as difficulty breathing, swelling, or rash, are observed, official safety guidelines describe that immediate discontinuation of the medicine and seeking emergency medical help are the necessary steps in such a situation.


Q: Is the potential for dependence or withdrawal symptoms associated with Persen?

Official safety information for the Valerian root extract in Persen notes that dependence and withdrawal symptoms may be associated with stopping the medicine after long-term use. This is related to its effect on the central nervous system. In general safety literature, a gradual reduction in dosage is sometimes discussed as a method to mitigate potential withdrawal symptoms when discontinuing prolonged use.


Q: Are there warnings about using Persen before driving or operating heavy machinery?

Official labeling explicitly includes a safety consideration warning. Due to the potential for sedative effects, the product may impair a person’s ability to drive a vehicle or operate heavy machinery. Assessing one's personal response to the medicine before engaging in such activities is commonly recommended.


Q: Can Persen affect an individual's mood or cause increased irritability?

Official side effect reports list 'nightmares' and 'vivid dreams' in the Psychiatric Disorders section. While not explicitly listing 'irritability,' general safety literature for Valerian has reported that some individuals may experience irritability or mental dullness. This suggests the product can have effects on mental state, which is a known possibility for CNS-modulating medicines.


Q: Do official patient information leaflets mention any dietary restrictions for Persen?

Official patient information leaflets do not typically list mandatory dietary restrictions or special food warnings. However, the most consistent and important instruction regarding consumption is the strict avoidance of excessive alcohol intake due to the risk of potentiating the sedative effects.


Q: Does the color or appearance of the Persen capsule indicate anything about its strength?

The color and appearance of a capsule are strictly defined by regulatory standards as part of the product’s identity and are documented in the excipient sections of the label. Manufacturers use these visual markers, along with any external printing, to help users and professionals quickly identify and distinguish between different strengths or products within the same brand line.


Q: What kind of regulatory oversight applies to a herbal preparation like Persen?

Persen is typically regulated as a traditional herbal medicinal product under authorities like the European Medicines Agency (EMA) and National Medicines Authorities. This regulatory classification means that its intended use is often supported primarily by long-standing traditional use rather than requiring extensive, full-scale clinical trial evidence needed for a full drug authorization.


Q: Is there a maximum recommended period for taking Persen continuously?

Official guidance recommends continuous use over a period of two to four weeks to achieve the optimal treatment effect for mild nervous tension or sleep. If symptoms persist or worsen after two weeks of continuous use, the official label advises consultation with a healthcare professional.


Q: Are there specific signs of overdose for Persen that are described in patient materials?

While a definitive list of symptoms for the specific combination in Persen may vary, general safety literature for Valerian root mentions that signs of overdose can include severe tiredness, chest tightness, abdominal pain, hand trembling, and dilation of the pupils. In the event of a suspected overdose, official patient safety information describes seeking immediate emergency medical attention as necessary.

How should Persen be stored and disposed of?

How to Store and Dispose of Persen

The storage and disposal of Persen must strictly adhere to the conditions mandated by official regulatory product information.

Storage Conditions

To maintain product stability, Persen must be stored at a temperature that does not exceed 25°C (Store below 25 C). The product should be kept in the original container, which must be tightly closed, to provide necessary protection from light and moisture. Consistent with all regulatory standards, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Persen must be disposed of in accordance with local legal requirements for pharmaceutical waste. To protect the environment, the medicine must not be discarded via wastewater (such as flushing down the toilet) or general household trash unless local regulations specifically permit it. Consumers should utilize local drug take-back programs or official collection points when available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Persen found in:

A-Z Index: